TOMA Biosciences Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
25
- Latest Deal Type
-
M&A
TOMA Biosciences General Information
Description
Developer of cancer testing technology created to provide the sequencing system to identify clinically meaningful changes in the DNA of cancer tumors. The company's cancer testing technology provides physicians with accurate information about the errors present in a patient's tumor through their digital molecular test that identifies genomic errors in a patient's tumor and provides information that can help physicians guide treatment, enabling laboratories and researchers to uncover genomic changes in tumors.
Contact Information
Website
www.tomabio.comCorporate Office
- 242 Howard Avenue
- Suite 242
- Holland, MI 49424
- United States
Corporate Office
- 242 Howard Avenue
- Suite 242
- Holland, MI 49424
- United States
TOMA Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Dec-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C1) | 01-Jul-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 01-Nov-2018 | Completed | Product Development | |||
| 2. Early Stage VC (Series B) | 21-Sep-2016 | $11.9M | $17.9M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Oct-2014 | $6.02M | $6.02M | Completed | Startup |
TOMA Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series B | 15,500,000 | $0.000010 | $0.08 | $1.04 | $1.04 | 1x | $1.04 | 14.3% |
| Series A | 10,136,395 | $0.000010 | $0.06 | $0.78 | $0.78 | 1x | $0.78 | 9.35% |
TOMA Biosciences Comparisons
Industry
Financing
Details
TOMA Biosciences Competitors (44)
One of TOMA Biosciences’s 44 competitors is Ambry Genetics, a Formerly PE-Backed company based in Aliso Viejo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Admera Health | Venture Capital-Backed | South Plainfield, NJ | ||||
| Menarini Silicon Biosystems | Formerly VC-backed | Castel Maggiore, Italy | ||||
| Biocept | Formerly VC-backed | San Diego, CA | ||||
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD |
TOMA Biosciences Patents
TOMA Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019070598-A1 | Library preparation for whole genome sequencing | Inactive | 04-Oct-2017 | ||
| EP-3414693-A1 | Systems and methods for analyzing nucelic acids | Inactive | 09-Feb-2016 | ||
| EP-3414693-A4 | Systems and methods for analyzing nucelic acids | Inactive | 09-Feb-2016 | ||
| WO-2017139492-A1 | Systems and methods for analyzing nucelic acids | Inactive | 09-Feb-2016 | ||
| US-20190050530-A1 | Systems and methods for analyzing nucleic acids | Inactive | 09-Feb-2016 | G16B30/00 |
TOMA Biosciences Signals
TOMA Biosciences Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alafi Capital Company | Venture Capital | Minority | ||
| Cambridge Global Advisors | Venture Capital | Minority | ||
| Cantilever Investors | Venture Capital | Minority | ||
| Correlation Ventures | Venture Capital | Minority | ||
| Frontier Angels | Angel Group | Minority |
TOMA Biosciences FAQs
-
When was TOMA Biosciences founded?
TOMA Biosciences was founded in 2013.
-
Where is TOMA Biosciences headquartered?
TOMA Biosciences is headquartered in Holland, MI.
-
What is the size of TOMA Biosciences?
TOMA Biosciences has 25 total employees.
-
What industry is TOMA Biosciences in?
TOMA Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is TOMA Biosciences a private or public company?
TOMA Biosciences is a Private company.
-
What is TOMA Biosciences’s current revenue?
The current revenue for TOMA Biosciences is .
-
How much funding has TOMA Biosciences raised over time?
TOMA Biosciences has raised $26.9M.
-
Who are TOMA Biosciences’s investors?
Alafi Capital Company, Cambridge Global Advisors, Cantilever Investors, Correlation Ventures, and Frontier Angels are 5 of 11 investors who have invested in TOMA Biosciences.
-
Who are TOMA Biosciences’s competitors?
Ambry Genetics, Admera Health, Menarini Silicon Biosystems, Biocept, and Personal Genome Diagnostics are some of the 44 competitors of TOMA Biosciences.
-
When was TOMA Biosciences acquired?
TOMA Biosciences was acquired on 01-Dec-2019.
-
Who acquired TOMA Biosciences?
TOMA Biosciences was acquired by Trident Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process